Answers are grounded in this paper and cite their sources.
An issue in the practice of oncology is the patient with a rare malignancy, where the challenge to the clinician is to rapidly understand the diagnosis and prioritise the best management approach. We present the case of a patient who was initially thought to have a malignant sarcoma and was eventually found to have an unusual, aggressive neuroendocrine tumour. This case stresses the importance of multi-disciplinary team (MDT) working and good communication and raises the pertinent issue of risk analysis in such settings. The case has greater relevance as it has led to a re-evaluation of how such cases are handled and heralded the introduction of a system of internal peer review.
No takes yet. Share an insight, caveat, or question.
Grant et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: